These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

363 related articles for article (PubMed ID: 34333075)

  • 21. Potential applications of nanoparticles for tumor microenvironment remodeling to ameliorate cancer immunotherapy.
    Bai Y; Wang Y; Zhang X; Fu J; Xing X; Wang C; Gao L; Liu Y; Shi L
    Int J Pharm; 2019 Oct; 570():118636. PubMed ID: 31446027
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Engineering Nanoparticles to Reprogram the Tumor Immune Microenvironment for Improved Cancer Immunotherapy.
    Saeed M; Gao J; Shi Y; Lammers T; Yu H
    Theranostics; 2019; 9(26):7981-8000. PubMed ID: 31754376
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunostimulatory Gene Therapy Using Oncolytic Viruses as Vehicles.
    Loskog A
    Viruses; 2015 Nov; 7(11):5780-91. PubMed ID: 26561829
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ultrasound nanotheranostics in fighting cancer: Advances and prospects.
    Zhou LQ; Li P; Cui XW; Dietrich CF
    Cancer Lett; 2020 Feb; 470():204-219. PubMed ID: 31790760
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reversal of the immunosuppressive tumor microenvironment by nanoparticle-based activation of immune-associated cells.
    Qi FL; Wang MF; Li BZ; Lu ZF; Nie GJ; Li SP
    Acta Pharmacol Sin; 2020 Jul; 41(7):895-901. PubMed ID: 32467568
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Perspectives on Recent Progress in Focused Ultrasound Immunotherapy.
    Sheybani ND; Price RJ
    Theranostics; 2019; 9(25):7749-7758. PubMed ID: 31695798
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nano-, micro-, and macroscale drug delivery systems for cancer immunotherapy.
    Huang P; Wang X; Liang X; Yang J; Zhang C; Kong D; Wang W
    Acta Biomater; 2019 Feb; 85():1-26. PubMed ID: 30579043
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Regulation of cancer-immunity cycle and tumor microenvironment by nanobiomaterials to enhance tumor immunotherapy.
    Yang J; Zhang C
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2020 Jul; 12(4):e1612. PubMed ID: 32114718
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Using nanoparticles for
    Gorbet MJ; Singh A; Mao C; Fiering S; Ranjan A
    Int J Hyperthermia; 2020 Dec; 37(3):18-33. PubMed ID: 33426995
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nanoparticle mediated cancer immunotherapy.
    Gupta J; Safdari HA; Hoque M
    Semin Cancer Biol; 2021 Feb; 69():307-324. PubMed ID: 32259643
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Engineering Nanoparticles toward the Modulation of Emerging Cancer Immunotherapy.
    Wang S; Sun Z; Hou Y
    Adv Healthc Mater; 2021 Mar; 10(5):e2000845. PubMed ID: 32790039
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A laser-activated multifunctional targeted nanoagent for imaging and gene therapy in a mouse xenograft model with retinoblastoma Y79 cells.
    Wu M; Xiong H; Zou H; Li M; Li P; Zhou Y; Xu Y; Jian J; Liu F; Zhao H; Wang Z; Zhou X
    Acta Biomater; 2018 Apr; 70():211-226. PubMed ID: 29452275
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Innovative cancer treatments that augment radiotherapy or chemo-therapy by the use of immunotherapy or gene therapy.
    Lucas R; Keisari Y
    Recent Pat Anticancer Drug Discov; 2006 Jun; 1(2):201-8. PubMed ID: 18221037
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Advances and Challenges of Nanoparticle-Based Macrophage Reprogramming for Cancer Immunotherapy.
    Kapitanova KS; Naumenko VA; Garanina AS; Melnikov PA; Abakumov MA; Alieva IB
    Biochemistry (Mosc); 2019 Jul; 84(7):729-745. PubMed ID: 31509725
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lipid-based microbubbles and ultrasound for therapeutic application.
    Omata D; Unga J; Suzuki R; Maruyama K
    Adv Drug Deliv Rev; 2020; 154-155():236-244. PubMed ID: 32659255
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rediscovery of nanoparticle-based therapeutics: boosting immunogenic cell death for potential application in cancer immunotherapy.
    Yang S; Sun IC; Hwang HS; Shim MK; Yoon HY; Kim K
    J Mater Chem B; 2021 May; 9(19):3983-4001. PubMed ID: 33909000
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Organic Sonodynamic Materials for Combination Cancer Immunotherapy.
    Zhang C; Pu K
    Adv Mater; 2023 Dec; 35(51):e2303059. PubMed ID: 37263297
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ultrasound/microbubble-mediated targeted delivery of anticancer microRNA-loaded nanoparticles to deep tissues in pigs.
    Di Ianni T; Bose RJC; Sukumar UK; Bachawal S; Wang H; Telichko A; Herickhoff C; Robinson E; Baker S; Vilches-Moure JG; Felt SA; Gambhir SS; Paulmurugan R; Dahl JD
    J Control Release; 2019 Sep; 309():1-10. PubMed ID: 31326463
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Microbubble-enhanced ultrasound-mediated gene transfer--towards the development of targeted gene therapy for cancer.
    Nomikou N; McHale AP
    Int J Hyperthermia; 2012; 28(4):300-10. PubMed ID: 22621732
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Combination Cancer Immunotherapy of Nanoparticle-Based Immunogenic Cell Death Inducers and Immune Checkpoint Inhibitors.
    Qi J; Jin F; Xu X; Du Y
    Int J Nanomedicine; 2021; 16():1435-1456. PubMed ID: 33654395
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.